Merge completes Confirma purchase

Merge Healthcare has completed its acquisition of Confirma, a developer of computer-aided detection (CAD) applications for MRI.

As part of the transaction the Milwaukee-based Merge issued approximately 5.4 million shares of Merge’s common stock to Confirma, valued at about $22 million. In addition, Merge will add approximately $2 million to Confirma’s existing cash balance to retire outstanding debt and fund transaction-related costs. Confirma shareholders approved the merger on Aug.28.

The Seattle-based Confirma will be renamed Merge CAD and operate as a business unit of Merge led by Paul Budak, a four-year Confirma veteran who most recently served as the vice president of research of development and operations. Prior to joining Confirma, Budak started and managed several technology companies in the Seattle area, according to Merge.

Around the web

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Trimed Popup
Trimed Popup